- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Pandemic influenza vaccine (h5n1) (live attenuated, nasal) is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- J07BB03 Influenza vaccine (live attenuated, nasal) · Influenza vaccine
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Biologic
- Yes
All presentations
No presentations of Pandemic influenza vaccine (h5n1) (live attenuated, nasal) are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Pandemic influenza vaccine (h5n1) (live attenuated, nasal) available for export from India?
No presentation of Pandemic influenza vaccine (h5n1) (live attenuated, nasal) is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Pandemic influenza vaccine (h5n1) (live attenuated, nasal) authorised in the European Union?
Yes. Pandemic influenza vaccine (h5n1) (live attenuated, nasal) has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Pandemic influenza vaccine (h5n1) (live attenuated, nasal) need cold chain shipping?
No listed presentation of Pandemic influenza vaccine (h5n1) (live attenuated, nasal) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Pandemic influenza vaccine (h5n1) (live attenuated, nasal) in?
Pandemic influenza vaccine (h5n1) (live attenuated, nasal) is classified under ATC code J07BB03 (Influenza vaccine (live attenuated, nasal)).
References
- Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune): European public assessment report (EPAR). European Medicines Agency. Retrieved 8 May 2026
Request Pandemic influenza vaccine (h5n1) (live attenuated, nasal) for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.